|
Name
|
Auflagedatum
|
Volumen
|
YTD-P
|
1-Y-P
|
3-Y-P
|
5-Y-P
|
|
Galileo - Biotech Innovation Fund
LU2226244361
USD / Acc. / Retail
|
31.03.2021
5,5 Jahre
|
50,38 |
+32,05% |
+67,85% |
+27,00% |
-49,54% |
|
JPMorgan Funds - Thematics - Genetic Therapies Fund
LU2050612402
USD / Acc. / Retail
|
24.10.2019
6,9 Jahre
|
354,06 |
+21,09% |
+47,92% |
+25,24% |
-22,34% |
|
PPF ("PMG Partners Funds") - Helix Biotechnology Fund
LU1230343250
USD / Acc. / Retail
|
21.10.2015
10,9 Jahre
|
37,35 |
+30,36% |
+71,16% |
+60,19% |
+2,37% |
|
Abaris Biotechnology Opportunities
LU2210105313
USD / Acc. / Retail
|
30.10.2020
5,9 Jahre
|
4,84 |
+20,42% |
+68,28% |
+116,34% |
+5,56% |
|
Protea Fund - Sectoral Biotech Opportunities Fund
LU1176840327
USD / Acc. / Retail
|
27.02.2015
11,6 Jahre
|
27,08 |
+11,08% |
+39,76% |
+38,28% |
+11,65% |
|
L&G Pharma Breakthrough UCITS ETF
IE00BF0H7608
USD / Acc. / Retail
|
18.01.2018
8,7 Jahre
|
21,23 |
+15,24% |
+31,56% |
+33,40% |
+18,93% |
|
Allianz Biotechnologie
DE0008481862
EUR / Dist. / Retail
|
09.01.1998
28,7 Jahre
|
295,06 |
+15,17% |
+38,96% |
+40,31% |
+19,04% |
|
Aescap Life Sciences
NL0012343958
EUR / Acc. / Retail
|
29.03.2016
10,5 Jahre
|
137,38 |
+7,62% |
+53,36% |
+66,76% |
+22,11% |
|
RH&PARTNER Investment Funds - RH&P Global Life Sciences Fund
LU0115986761
USD / Acc. / Retail
|
06.09.2000
26,0 Jahre
|
72,19 |
+21,76% |
+40,64% |
+39,68% |
+24,21% |
|
DWS ESG Biotech
DE0009769976
EUR / Acc. / Retail
|
16.08.1999
27,1 Jahre
|
385,83 |
+11,36% |
+40,65% |
+43,74% |
+28,75% |